₂Saarene Panossian

Summary for 2006 [at-glance overview of Saarene Panossian work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Saarene Panossian. According to available data, in 2006 Saarene Panossian published at least 2 articles. This work was completed in collaboration with several authors including Rebbeck, Timothy R and Gruber, Stephen B. Many other authors have collaborated with Saarene Panossian as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that Saarene Panossian professional interests are focused around "estrogen replacement therapy", "hormone replacement therapy" and "population-based study natural". These might also be referred to as "replacement therapy", "endometrial cancer" or "estrogen replacement". Statistical analysis shows that Saarene Panossian's writing is likely to contains terms "therapy", "replacement", "estrogen", "risk", "ci" and "variant".

The majority of Saarene Panossian articles are affiliated with Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 904 Blockley Hall, 423 Guardian Dr., Philadelphia, PA Pennsylvania 19104-6021, USA. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Saarene Panossian]

Do you know Saarene Panossian who matches the profile above? Click the photo and let us know!

Alternative names (0) [other authors with names similar to Saarene Panossian]

none

Year 2006 Charts [Saarene Panossian frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Saarene Panossian publication and funding history for the range of years]

Emails (2) [email addresses extracted from Saarene Panossian affiliations]

hidden to prevent spam, click here to reveal

Saarene Panossian Coauthors (29) [all coauthors with the number of joint publications]

2

1

1

1

1

1

1

1

1

₈Gallagher, Richard P

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Affiliations (1) [condensed summary of the Saarene Panossian affiliations, the leading number and the color conveys importance]

₂Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 904 Blockley Hall, 423 Guardian Dr., Philadelphia, PA Pennsylvania 19104-6021, USA.

Key Opinion Leader In [Saarene Panossian is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (28) [keywords assigned to Saarene Panossian articles by PubMed, the leading number and the color conveys importance]

₂Humans | ₂Middle Aged | ₂Female | ₁Arylsulfotransferase | ₁Polymorphism, Genetic | ₁Genetic Variation | ₁Genotype | ₁Sulfotransferases | ₁Cytochrome P-450 Enzyme System | ₁Estrogen Replacement Therapy | ₁Endometrial Neoplasms | ₁Gene Frequency | ₁Cytochrome P-450 CYP1A2 | ₁Odds Ratio | ₁Adult | ₁Philadelphia | ₁Logistic Models | ₁Melanoma | ₁Cytochrome P-450 CYP1A1 | ₁Estrogens | ₁Polymerase Chain Reaction | ₁Male | ₁Progesterone | ₁Glucuronosyltransferase | ₁Receptor, Melanocortin, Type 1 | ₁Case-Control Studies | ₁Sequence Analysis, DNA | ₁Aged

Saarene Panossian Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Saarene Panossian might be a good expert witness on these terms]

₇therapy | ₇replacement | ₆estrogen | ₅risk | ₅ci | ₅variant | ₄among | ₄endometrial | ₄hormone | ₄cancer | ₄melanoma | ₄use | ₃variants | ₃carrying | ₃sulfation | ₃study | ₃may | ₃sult1a1 | ₃statistically | ₃mc1r | ₂receptor | ₂natural | ₂previously | ₂variation | ₂melanocortin-1 | ₂pigmentation | ₂characteristics | ₂similar | ₂adjusted | ₂population-based | ₂gene | ₂genes
₇replacement therapy | ₄endometrial cancer | ₄estrogen replacement | ₃hormone replacement | ₂study natural | ₂cancer risk | ₂estrogen sulfation | ₂melanocortin-1 receptor | ₂receptor gene | ₂genes hormone | ₂among carrying | ₂therapy endometrial | ₂sulfation genes | ₂population-based study | ₂variation melanocortin-1 | ₂gene melanoma | ₂natural variation | ₂pigmentation characteristics | ₂adjusted ci | ₂risk endometrial | ₂sult1a1 allele | ₂therapy use | ₂use estrogen | ₂carrying variant | ₂statistically significant | ₂variant ci | ₂long-term use | ₁non-r mc1r | ₁associated functionally | ₁previously identified | ₁3-2 among | ₁regions categories
₄estrogen replacement therapy | ₃hormone replacement therapy | ₂population-based study natural | ₂receptor gene melanoma | ₂genes hormone replacement | ₂study natural variation | ₂sulfation genes hormone | ₂variation melanocortin-1 receptor | ₂therapy endometrial cancer | ₂estrogen sulfation genes | ₂melanocortin-1 receptor gene | ₂natural variation melanocortin-1 | ₂replacement therapy endometrial | ₂endometrial cancer risk | ₂replacement therapy use | ₂use estrogen replacement | ₂risk endometrial cancer | ₂long-term use estrogen | ₁statistically significant interaction | ₁combined hormone replacement | ₁statistically significantly higher | ₁genotypes regulate steroid | ₁risk suggest associations | ₁part due study | ₁therapy use sult1a1 | ₁therapy risk endometrial | ₁effects similar | ₁significantly higher risk | ₁ci sult1a1 allele | ₁similar among individuals | ₁controls cases likely | ₁mc1r variants melanoma

Reader's Comments (0) [comments posted by readers of Saarene Panossian profile]